(Q50114940)

English

Long-term experience with etanercept in the treatment of rheumatoid arthritis in elderly and younger patients: patient-reported outcomes from multiple controlled and open-label extension studies

scientific article published in January 2006

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 February 2018

http://europepmc.org/abstract/MED/16536638

Long-term experience with etanercept in the treatment of rheumatoid arthritis in elderly and younger patients: patient-reported outcomes from multiple controlled and open-label extension studies (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 February 2018

http://europepmc.org/abstract/MED/16536638

rheumatoid arthritis

1 reference

based on heuristic

inferred from title

author name string

Michael H Schiff

1

1 reference

Europe PubMed Central

PubMed publication ID

25 February 2018

http://europepmc.org/abstract/MED/16536638

Elaine B Yu

2

1 reference

Europe PubMed Central

PubMed publication ID

25 February 2018

http://europepmc.org/abstract/MED/16536638

Michael E Weinblatt

3

1 reference

Europe PubMed Central

PubMed publication ID

25 February 2018

http://europepmc.org/abstract/MED/16536638

Larry W Moreland

4

1 reference

Europe PubMed Central

PubMed publication ID

25 February 2018

http://europepmc.org/abstract/MED/16536638

Mark C Genovese

5

1 reference

Europe PubMed Central

PubMed publication ID

25 February 2018

http://europepmc.org/abstract/MED/16536638

Barbara White

6

1 reference

Europe PubMed Central

PubMed publication ID

25 February 2018

http://europepmc.org/abstract/MED/16536638

Amitabh Singh

7

1 reference

Europe PubMed Central

PubMed publication ID

25 February 2018

http://europepmc.org/abstract/MED/16536638

Yun Chon

8

1 reference

Europe PubMed Central

PubMed publication ID

25 February 2018

http://europepmc.org/abstract/MED/16536638

J Michael Woolley

9

1 reference

Europe PubMed Central

PubMed publication ID

25 February 2018

http://europepmc.org/abstract/MED/16536638

publication date

1 January 2006

1 reference

Europe PubMed Central

PubMed publication ID

25 February 2018

http://europepmc.org/abstract/MED/16536638

1 reference

Europe PubMed Central

PubMed publication ID

25 February 2018

http://europepmc.org/abstract/MED/16536638

23

1 reference

Europe PubMed Central

PubMed publication ID

25 February 2018

http://europepmc.org/abstract/MED/16536638

2

1 reference

Europe PubMed Central

PubMed publication ID

25 February 2018

http://europepmc.org/abstract/MED/16536638

167-178

1 reference

Europe PubMed Central

PubMed publication ID

25 February 2018

http://europepmc.org/abstract/MED/16536638

Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial.

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200623020-00006

21 January 2018

Running and the development of disability with age.

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200623020-00006

21 January 2018

Risk factors for physical disability in an aging cohort: the NHANES I Epidemiologic Followup Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/16536638

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Normative values for the Health Assessment Questionnaire disability index: benchmarking disability in the general population

1 reference

https://pubmed.ncbi.nlm.nih.gov/16536638

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Health-related quality of life in early rheumatoid arthritis: impact of disease and treatment response

1 reference

https://pubmed.ncbi.nlm.nih.gov/16536638

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16536638

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Etanercept (Enbrel) in patients with rheumatoid arthritis with recent onset versus established disease: improvement in disability

1 reference

https://pubmed.ncbi.nlm.nih.gov/16536638

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16536638

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early rheumatoid arthritis patients: relationship of age

1 reference

https://pubmed.ncbi.nlm.nih.gov/16536638

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Physical function and health related quality of life: analysis of 2-year data from randomized, controlled studies of leflunomide, sulfasalazine, or methotrexate in patients with active rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16536638

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Minimum important difference between patients with rheumatoid arthritis: the patient's perspective

1 reference

https://pubmed.ncbi.nlm.nih.gov/16536638

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An assessment of the annual and long-term direct costs of rheumatoid arthritis: the impact of poor function and functional decline

1 reference

https://pubmed.ncbi.nlm.nih.gov/16536638

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patient reported outcomes in a trial of combination therapy with etanercept and methotrexate for rheumatoid arthritis: the TEMPO trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/16536638

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Stanford Health Assessment Questionnaire: a review of its history, issues, progress, and documentation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16536638

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predicting mortality in patients with rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16536638

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16536638

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-cont

1 reference

https://pubmed.ncbi.nlm.nih.gov/16536638

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/16536638

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Measurement of patient outcome in arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16536638

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/16536638

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Health-related quality of life and functional status of patients with rheumatoid arthritis randomly assigned to receive etanercept or placebo

1 reference

https://pubmed.ncbi.nlm.nih.gov/16536638

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate

1 reference

https://pubmed.ncbi.nlm.nih.gov/16536638

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A rationale for the use of summary measurements for the assessment of the effects of rheumatoid arthritis therapies

1 reference

https://pubmed.ncbi.nlm.nih.gov/16536638

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expanding the definition of clinical differences: from minimally clinically important differences to really important differences. Analyses in 8931 patients with rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16536638

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Etanercept versus methotrexate in patients with early rheumatoid arthritis: two-year radiographic and clinical outcomes

1 reference

https://pubmed.ncbi.nlm.nih.gov/16536638

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term safety and efficacy of etanercept in patients with rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16536638

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumati

1 reference

https://pubmed.ncbi.nlm.nih.gov/16536638

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Response to etanercept (Enbrel) in elderly patients with rheumatoid arthritis: a retrospective analysis of clinical trial results.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16536638

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00002512-200623020-00006

1 reference

Europe PubMed Central

PubMed publication ID

25 February 2018

http://europepmc.org/abstract/MED/16536638

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 February 2018

http://europepmc.org/abstract/MED/16536638

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50114940&oldid=2241049466"